|
OGT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.631800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.979990E-01 |
| Normal-vs-Stage2 |
2.300600E-01 |
| Normal-vs-Stage3 |
5.503800E-01 |
| Normal-vs-Stage4 |
2.139400E-01 |
| Stage1-vs-Stage2 |
2.475500E-02 |
| Stage1-vs-Stage3 |
2.423800E-02 |
| Stage1-vs-Stage4 |
5.270400E-01 |
| Stage2-vs-Stage3 |
4.546600E-01 |
| Stage2-vs-Stage4 |
5.106100E-02 |
| Stage3-vs-Stage4 |
1.027570E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.721600E-01 |
| Normal-vs-AfricanAmerican |
9.005800E-01 |
| Normal-vs-Asian |
3.595500E-03 |
| Caucasian-vs-AfricanAmerican |
7.771400E-01 |
| Caucasian-vs-Asian |
1.103540E-02 |
| AfricanAmerican-vs-Asian |
3.768400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.300400E-01 |
| Normal-vs-Female |
5.370000E-01 |
| Male-vs-Female |
7.110600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.031380E-01 |
| Normal-vs-Age(41-60Yrs) |
6.693600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.681600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.728800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.400180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.442100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.184400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.980400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.428100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.924400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.58159999999708E-05 |
| Classical-VS-Follicular |
7.57710000000023E-05 |
| Classical-VS-Other |
7.636600E-01 |
| Classical-VS-Normal |
4.076000E-02 |
| Tall-VS-Follicular |
9.190200E-01 |
| Tall-VS-Other |
3.338200E-01 |
| Tall-VS-Normal |
1.408830E-01 |
| Follicular-VS-Other |
3.119200E-01 |
| Follicular-VS-Normal |
1.049610E-01 |
| Other-VS-Normal |
6.487800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.880000E-01 |
| Normal-vs-N1 |
2.750100E-02 |
| N0-vs-N1 |
1.397690E-02 |
|
|
